quality of life

Endovascular Repair of Abdominal Aorta, lower mortality rates than conventional open surgery in younger than 70.

Original title: Long Term Comparison of Endovascular and Repair of Abdominal Aortic Aneurysm (OVER TRIAL) Reference: Frank A. Lederle, et al. NEJM 367;24:1988-1997 Randomized studies had shown that the endovascular approach reduces mortality, yet its long term evolution remained a concern.  The aim of this study was to analyze long term evolution of EVAR device implantation vs. conventional...

TAVI en insuficiencia aórtica pura

Short-Term Outcomes of TAVR in Asymptomatic or Minimally Symptomatic Patients

Aortic valve replacement (AVR) is indicated for symptomatic aortic stenosis (AS), while close follow-up is recommended for asymptomatic patients, unless they have elevated aortic gradients, low ejection fraction, or abnormal stress tests. However, the optimal timing to perform AVR is uncertain, especially with recent evidence suggesting that patients with AS associated with signs of myocardial...

SOLACI-SOCIME 2022 Highlighted Scientific Sessions

INDUSTRY SPONSORED ACTIVITIES Just like every year, the unconditional support of the industry to SOLACI Congress is a fundamental aspect to guarantee the academic excellence and quality of our scientific content. This is why we are inviting you to find out more about the important activities we will be carrying out at SOLACI-SOCIME 2022. Register...

ESC 2021 | GREENNESS: Sorpresivo nuevo factor protector contra la enfermedad cardiovascular

ESC 2021 | GREENNESS: Surprising New Protective Factor against Cardiovascular Disease

What Is “Greenness”? This factor—which generally refers to the proximity to vegetation, as measured by satellite pictures—could serve as a new protection against cardiovascular disease. During five years (the total research time), this study compared individuals who lived in the lowest tercile of “greenness” with those who lived in the highest tercile (i.e., those who...

Resultados alentadores en la válvula mitral percutánea en los pacientes complejos

Improvements in COAPT Trial for Functional Mitral Regurgitation

Patients with heart failure and moderate-to-severe secondary mitral regurgitation may benefit from transcatheter mitral valve repair. There are benefits at 3 years, even in hard points such as mortality rate. The COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial showed fewer heart failure hospitalizations and...

SENTINEL: Protección cerebral en TAVI

Screening for Intracranial Aneurysm in Patients with Coarctation: Is It Cost-Effective?

Patients with a history of coarctation of the aorta have a higher prevalence of intracranial aneurysm and frequently suffer subarachnoid hemorrhage at younger ages than the general population. Read also: FREEDOM with FFR: Different Outcomes? Adding a screening stage at age 30—instead of just at ages 10 and 20—is cost-effective. Known data about the prognosis...

Dieta proinflamatoria y su potencial para desencadenar eventos cardiovasculares

What Is the Healthiest Diet?

This review published in JACC focuses on the foods we shood consume rather than the foods we should avoid eating (the latter being the most common focus).  In this regard, the Mediterranean diet, with fish as protein source, should be the gold standard, the ultimate goal being to extend life expectancy. Promoting cardiovascular health based...

The Fellow’s Corner | 2nd Clinical Case: An Explosive Mission

Read the case presentation and join the conversation through the comments in this post! Case Introduction: An Explosive Mission! 56-year-old male patient Severe smoker Hypertension Dyslipidemia Sedentary lifestyle and stress A sibling suffered from an acute myocardial infraction Cardiac markers: Standard angina, intensity of 8-9/10, 3-to-4-h long, and dyspnea (on and off for the past...

AHA 2019 | ISCHEMIA-CKD: insuficiencia renal crónica y enfermedad coronaria estable

AHA 2019 | ISCHEMIA-CKD: Chronic Kidney Disease and Stable Coronary Disease

Among patients in the main ISCHEMIA trial, those with chronic kidney disease are a particularly high-risk subgroup. However, an invasive strategy with coronary angiography and revascularization did not improve the rate of events, similarly to what happened in the general population for the aforementioned trial. The rate of death or acute myocardial infarction was 36.4%...

Top